PL2857017T3 - Zastosowanie dimiracetamu do leczenia chronicznego bólu - Google Patents

Zastosowanie dimiracetamu do leczenia chronicznego bólu

Info

Publication number
PL2857017T3
PL2857017T3 PL14004202.9T PL14004202T PL2857017T3 PL 2857017 T3 PL2857017 T3 PL 2857017T3 PL 14004202 T PL14004202 T PL 14004202T PL 2857017 T3 PL2857017 T3 PL 2857017T3
Authority
PL
Poland
Prior art keywords
dimiracetam
treatment
chronic pain
pain
chronic
Prior art date
Application number
PL14004202.9T
Other languages
English (en)
Inventor
Carlo Farina
Carla Ghelardini
Paola Petrillo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2857017T3 publication Critical patent/PL2857017T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14004202.9T 2007-04-16 2008-04-15 Zastosowanie dimiracetamu do leczenia chronicznego bólu PL2857017T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000770A ITMI20070770A1 (it) 2007-04-16 2007-04-16 Impiego di dimiracetam nel trattamento del dolore cronico

Publications (1)

Publication Number Publication Date
PL2857017T3 true PL2857017T3 (pl) 2016-11-30

Family

ID=39628738

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08749565T PL2146706T3 (pl) 2007-04-16 2008-04-15 Zastosowanie dimiracetamu do leczenia chronicznego bólu
PL14004202.9T PL2857017T3 (pl) 2007-04-16 2008-04-15 Zastosowanie dimiracetamu do leczenia chronicznego bólu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL08749565T PL2146706T3 (pl) 2007-04-16 2008-04-15 Zastosowanie dimiracetamu do leczenia chronicznego bólu

Country Status (16)

Country Link
US (2) US7989421B2 (pl)
EP (3) EP2146706B1 (pl)
JP (1) JP5409602B2 (pl)
CN (2) CN101677984A (pl)
AU (1) AU2008237901B2 (pl)
BR (1) BRPI0810475A2 (pl)
CA (1) CA2684363C (pl)
EA (2) EA019354B1 (pl)
ES (2) ES2584161T3 (pl)
HK (1) HK1209053A1 (pl)
IL (2) IL201498A (pl)
IT (1) ITMI20070770A1 (pl)
MX (1) MX2009011380A (pl)
PL (2) PL2146706T3 (pl)
WO (1) WO2008125674A1 (pl)
ZA (1) ZA200906991B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
WO2012013640A1 (en) 2010-07-26 2012-02-02 Neurotune Ag Process for the preparation of dimiracetam
CA2828238A1 (en) * 2010-10-29 2012-05-03 Neurotune Ag Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
WO2012137645A1 (ja) * 2011-04-07 2012-10-11 旭化成ファーマ株式会社 抗癌剤に起因する異痛症の予防及び／又は治療剤
CN102743372B (zh) * 2012-06-30 2015-09-09 江苏省中医药研究院 一种化疗致血痹动物模型建立方法
JOP20190251A1 (ar) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
US20200361973A1 (en) * 2017-11-21 2020-11-19 Medoncare Pharmaceutical Co., Ltd. Combination product comprising dicycloplatin and preparation method and use thereof
DE102019107619A1 (de) 2019-03-25 2020-10-01 Mondi Ag Verpackungsbeutel aus einem Kunststoffgewebeverbund
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324219A1 (de) * 1983-07-05 1985-01-17 Hoechst Ag, 6230 Frankfurt Mehrlagige elektroisolierfolie
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
IT1233860B (it) 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
GB9123641D0 (en) 1991-11-07 1992-01-02 Isf Spa Process
ES2287039T3 (es) * 1999-12-01 2007-12-16 Ucb, S.A. Un derivado de pirrolidinacetamida para el tratamiento de dolor cronico o neuropatico.
KR100823668B1 (ko) * 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
CN103284997A (zh) 2013-09-11
MX2009011380A (es) 2010-07-06
CA2684363A1 (en) 2008-10-23
AU2008237901B2 (en) 2013-06-27
US20100129469A1 (en) 2010-05-27
EP2620149A3 (en) 2013-08-07
IL218851A (en) 2013-09-30
ES2584161T3 (es) 2016-09-26
EP2857017A3 (en) 2015-05-06
EP2857017B1 (en) 2016-05-25
US7989421B2 (en) 2011-08-02
EP2146706B1 (en) 2015-02-25
EA022867B1 (ru) 2016-03-31
JP2010524882A (ja) 2010-07-22
PL2146706T3 (pl) 2015-07-31
EA200901237A1 (ru) 2010-04-30
ZA200906991B (en) 2011-03-30
ES2536631T3 (es) 2015-05-27
EP2857017A2 (en) 2015-04-08
ITMI20070770A1 (it) 2008-10-17
AU2008237901A1 (en) 2008-10-23
IL201498A0 (en) 2010-05-31
HK1209053A1 (zh) 2016-03-24
BRPI0810475A2 (pt) 2015-10-20
EP2620149A2 (en) 2013-07-31
EA019354B1 (ru) 2014-03-31
IL218851A0 (en) 2012-05-31
CN101677984A (zh) 2010-03-24
EA201300826A1 (ru) 2013-11-29
CA2684363C (en) 2016-02-09
CN103284997B (zh) 2015-06-03
JP5409602B2 (ja) 2014-02-05
US20110251250A1 (en) 2011-10-13
WO2008125674A1 (en) 2008-10-23
IL201498A (en) 2013-10-31
US8222241B2 (en) 2012-07-17
EP2146706A1 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
HK1209053A1 (zh) 地來西坦在慢性疼痛的治療中的用途
GB0719803D0 (en) Therapeutic compounds and their use
GB0719644D0 (en) Therapeutic compounds and their use
PL1912650T3 (pl) Zastosowanie flibanseryny w leczeniu otyłości
PL1978947T3 (pl) Nitrooksypochodne do zastosowania w leczeniu dystrofii mięśniowych
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
IL205562A0 (en) Benzodiazepinone compounds useful in the treatment of skin conditions
GB0724251D0 (en) Therapeutic compounds and their use
HK1255227A1 (zh) 疼痛治療
HK1203160A1 (en) Tapentadol for the treatment of pain in arthrosis (tapentadol)
GB0722680D0 (en) Therapeutic compounds and their use
HK1160471A1 (en) Aminophosphinic derivatives that can be used in the treatment of pain
IL207965A (en) Compounds to treat or prevent pain
GB0822486D0 (en) Compounds for use in the treatment of pain
HK1143756A1 (en) Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
HK1151971A1 (en) Compounds for use in the treatment of cancer
ZA201005875B (en) Use of interleukin-1 conjugates in the treatment of diabetes
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
EP2231163A4 (en) COMPOUNDS AND THEIR THERAPEUTIC USE
EP2124950A4 (en) PAIN TREATMENT WITH NALOXONE
GB0705517D0 (en) Therapeutic compounds and their use
GB0722338D0 (en) Novel use and treatment
GB0819103D0 (en) Raphaine compounds and their use in therapy
GB0725166D0 (en) The use of ketoprofen in treating hemorrhoids